Effect of stabilizing versus destabilizing interactions on plasminogen activator inhibitor-1

被引:15
作者
Vleugels, N [1 ]
Leys, J [1 ]
Knockaert, I [1 ]
Declerck, PJ [1 ]
机构
[1] Katholieke Univ Leuven, Fac Pharmaceut Sci, Lab Pharmaceut Biol & Phytopharmacol, B-3000 Louvain, Belgium
关键词
serpins; PAI-1; mutagenesis; stability;
D O I
10.1055/s-0037-1614130
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasminogen activator inhibitor-1 (PAI-1) is a unique member of the serpin family, as it spontaneously converts into a latent conformation. However, the exact mechanism of this conversion is not known. Previous studies reported that neutralizing monoclonal antibodies as well as reversal or removal of charges on the s3C-s4C turn results in a destabilization of PAI-1 leading to an accelerated conversion to its latent form. In this study the effect of the reversal or removal of charges in this "gate region" (R186E/R187E, H190E/K191E, H190L/K191L and R356E) on a stable PAI-l-variant (PAI-l-stab) was investigated. Whereas PAI-l-stab has a half-life of 150 +/- 66 h, PAI-1-stab-R186E-R187E, PAI-1-stab-H190E-K191E, PAI-1-srab-H190L-K191L and PAI-1-stab-R356E have a strongly decreased half-life (p < 0.005 versus PAI-1-stab) of 175 +/- 48 min, 75 +/- 34 min, 68 +/- 38 min and 79 +/- 16 min, respectively. Wild-type PAI-1 (wtPAI-1) had a half-life of 55 +/- 19 min. These data indicate that the stabilization induced by the mutated residues in PAI-1-stab is counteracted by the additional mutations, resulting in half-lives similar to that of wtPAI-1, thereby suggesting that the stabilizing and destabilizing forces act mainly independently in these mutants. Extrapolation of these data to other (stable) serpins leads to the hypothesis that the s3C-s4C turn and the distal hinge region of the reactive site loop plays a role for the stability of serpins in general.
引用
收藏
页码:871 / 875
页数:5
相关论文
共 29 条
  • [1] MECHANISMS CONTRIBUTING TO THE CONFORMATIONAL AND FUNCTIONAL FLEXIBILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1
    AERTGEERTS, K
    DEBONDT, HL
    DERANTER, CJ
    DECLERCK, PJ
    [J]. NATURE STRUCTURAL BIOLOGY, 1995, 2 (10): : 891 - 897
  • [2] AUDENAERT AM, 1994, J BIOL CHEM, V269, P19559
  • [3] MOLECULAR EVOLUTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 FUNCTIONAL STABILITY
    BERKENPAS, MB
    LAWRENCE, DA
    GINSBURG, D
    [J]. EMBO JOURNAL, 1995, 14 (13) : 2969 - 2977
  • [4] Chang WSW, 1997, PROTEIN SCI, V6, P89
  • [5] Neutralization of plasminogen activator inhibitor-1 inhibitory properties: Identification of two different mechanisms
    Debrock, S
    Declerck, PJ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1997, 1337 (02): : 257 - 266
  • [6] DECLERCK PJ, 1992, J BIOL CHEM, V267, P11693
  • [7] Type-1 plasminogen-activator inhibitor - Conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility
    Egelund, R
    Schousboe, SL
    SottrupJensen, L
    Rodenburg, KW
    Andreasen, PA
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 248 (03): : 775 - 785
  • [8] Construction and characterization of plasminogen activator inhibitor-1 mutants in which part of the active site loop is deleted
    Gils, A
    Knockaert, I
    Declerck, PJ
    [J]. FIBRINOLYSIS & PROTEOLYSIS, 1997, 11 (5-6): : 265 - 271
  • [9] Proteinase specificity and functional diversity in po plasminogen activator inhibitor 1
    Gils, A
    Declerck, PJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (19) : 12662 - 12666
  • [10] Gils A, 1998, THROMB HAEMOSTASIS, V80, P531